Internet of Things
The Internet of Things is radically changing the way we work, do business, and live. IoT products can provide huge benefits – and add potential challenges. We’re here to help tackle these challenges and thrive.
The Internet of Things (IoT) is changing virtually every industry. Communication, cybersecurity, healthcare, manufacturing, energy, and beyond – IoT’s applications are practically limitless. So are the opportunities and challenges IoT presents. To compete, you need lawyers with knowledge of and solutions to current and emerging IoT issues to keep you a step ahead.
IoT applications help objects connect to the internet and to each other using built-in sensors that collect and exchange large amounts of data. As sensors and data storage become more affordable, data analytics and machine connectivity are transforming smart cities, supply chains, transport systems, connected buildings, digital health and telemedicine, retail and wearable technologies, homes, and automobiles.
“DLA Piper’s global reach enables us to help you navigate this vast, shifting landscape and support the launch of new IoT products worldwide.”
Our global IoT team advises established and emerging companies on IoT issues across practice areas and regions. We bring together technology and sourcing lawyers as well as data protection, telecom, intellectual property, media, life sciences, and commercial law practitioners to look at issues from every angle.
We’re at the forefront of this increasingly connected digital world. Members of our team communicate closely with data protection, telecom, and consumer protection regulators and legislators to push for a regulatory environment that fosters the growth of the IoT.
IoT projects – like the data that drives them – are global in nature and are often replicated in several jurisdictions. DLA Piper’s global reach enables us to help you navigate this vast, shifting landscape and support the launch of new IoT products worldwide.
News and insights
European Medicines Agency opens dialogue on use of AI in pharmaceutical life cycle
24 July 2023 .5 minute read